A phase 3 trial shows tradipitant significantly reduced semaglutide-induced vomiting and severe nausea in adults with overweight or obesity.
For patients undergoing cancer resection, physical activity (PA) is associated with a reduced risk for postoperative delirium (POD).
Testosterone therapy is associated with an increased risk for incident cardiovascular disease (CVD) among postmenopausal women.